29-10-2024 |
PM |
|
PFE |
Pfizer, Inc. |
161,220 |
1.06 |
0.64 |
-0.17 |
Pfizer Non-GAAP EPS of $1.06 beats by $0.45, revenue of $17.7B beats by $2.83B [10/29/2024 6:46 AM] |
28.43 |
-0.43 (-1.47%) |
29.08 |
0.22 (0.76%) |
25.20 - 31.54 |
63,118,163 |
27,560,000 |
11,983,725 |
|
|
30-07-2024 |
PM |
|
PFE |
Pfizer, Inc. |
171,020 |
0.60 |
0.45 |
0.67 |
Pfizer Non-GAAP EPS of $0.60 beats by $0.14, revenue of $13.28B beats by $260M [7/30/2024 6:47 AM] |
31.52 |
0.80 (2.59%) |
31.03 |
0.31 (1.01%) |
25.20 - 37.19 |
61,298,588 |
37,090,000 |
5,164,053 |
|
|
01-05-2024 |
PM |
|
PFE |
Pfizer, Inc. |
144,780 |
0.82 |
0.56 |
1.23 |
Pfizer beats top-line and bottom-line estimates; reaffirms FY24 outlook [5/1/2024 6:48 AM] |
27.21 |
1.59 (6.23%) |
26.35 |
0.73 (2.85%) |
25.20 - 40.37 |
72,904,813 |
37,640,000 |
3,664,780 |
|
|
30-01-2024 |
PM |
|
PFE |
Pfizer, Inc. |
155,110 |
0.10 |
-0.19 |
1.14 |
Pfizer reports mixed Q4 results; reaffirms FY24 outlook [1/30/2024 6:47 AM] |
27.08 |
-0.40 (-1.46%) |
27.85 |
0.37 (1.35%) |
25.76 - 44.46 |
66,631,493 |
43,760,000 |
5,510,964 |
|
|
31-10-2023 |
PM |
|
PFE |
Pfizer, Inc. |
175,930 |
-0.17 |
-0.19 |
1.78 |
Pfizer reports mixed Q3 earnings; reaffirms FY23 outlook [10/31/2023 6:47 AM] |
30.56 |
0.01 (0.03%) |
30.28 |
-0.27 (-0.88%) |
29.70 - 54.93 |
35,619,856 |
31,590,000 |
576,753 |
|
|
01-08-2023 |
PM |
|
PFE |
Pfizer, Inc. |
203,630 |
0.67 |
0.57 |
2.04 |
Pfizer reports mixed Q2 earnings; narrows FY23 outlook [8/1/2023 6:48 AM] |
35.59 |
-0.47 (-1.29%) |
35.92 |
-0.14 (-0.39%) |
35.35 - 54.93 |
34,736,393 |
23,980,000 |
1,125,250 |
|
|
02-05-2023 |
PM |
6:45 AM ET (May 2) |
PFE |
Pfizer, Inc. |
218,660 |
1.23 |
1.00 |
1.62 |
Pfizer beats Q1 top and bottom line estimates; reaffirms FY23 outlook [5/2/2023 6:49 AM] |
39.08 |
-0.13 (-0.34%) |
39.20 |
-0.01 (-0.03%) |
38.31 - 54.93 |
33,571,202 |
20,700,000 |
787,692 |
|
|
31-01-2023 |
PM |
6:45 AM ET (Jan 31) |
PFE |
Pfizer, Inc. |
248,390 |
1.14 |
1.04 |
1.08 |
Pfizer Non-GAAP EPS of $1.14 beats by $0.10, revenue of $24.3B misses by $100M [1/31/2023 6:46 AM] |
44.24 |
0.69 (1.58%) |
42.75 |
-0.80 (-1.84%) |
41.45 - 56.32 |
37,460,385 |
26,080,000 |
2,367,450 |
|
|
01-11-2022 |
PM |
6:45 AM ET (Nov 1) |
PFE |
Pfizer, Inc. |
266,190 |
1.78 |
1.47 |
1.34 |
Pfizer Non-GAAP EPS of $1.78 beats by $0.38, revenue of $22.6B beats by $1.5B, raises FY22 outlook [11/1/2022 6:46 AM] |
48.06 |
1.52 (3.25%) |
48.04 |
1.49 (3.20%) |
41.45 - 61.71 |
24,764,544 |
24,350,000 |
826,265 |
|
-
Studies questioning efficacy of Omicron boosters were too small – FDA [10/31/2022 1:21 PM]
-
All eyes on Pfizer Q3 results as industry faces slowdown in COVID products [10/31/2022 12:26 PM]
-
Pfizer Non-GAAP EPS of $1.78 beats by $0.38, revenue of $22.6B beats by $1.5B, raises FY22 outlook [11/1/2022 6:46 AM]
-
Pfizer raises outlook even as COVID vaccine sales drop 66% in Q3 [11/1/2022 7:46 AM]
-
Pfizer maternal RSV vaccine for infants shows 81.8% efficacy vs severe disease [11/1/2022 7:57 AM]
-
Pfizer says late-stage trial of RSV vaccine proved effective in reducing risk in very young children [Nov-01-22 06:48AM]
-
PFIZER REPORTS STRONG THIRD-QUARTER 2022 RESULTS AND RAISES 2022 OUTLOOK [Nov-01-22 06:45AM]
-
RSV Vaccine Protected Infants From Severe Cases, Pfizer Study Finds [Nov-01-22 06:30AM]
-
Pfizer says maternal RSV vaccine prevents severe infection in infants [Nov-01-22 06:30AM]
-
Pfizer Announces Positive Top-Line Data of Phase 3 Global Maternal Immunization Trial for its Bivalent Respiratory Syncytial Virus (RSV) Vaccine Candidate [Nov-01-22 06:30AM]
-
Stocks Edge Higher, Toyota, Big Oil, AMD And Pfizer In Focus - Five Things To Know [Nov-01-22 05:15AM]
-
3 Things to Watch When Pfizer Announces Earnings [Oct-31-22 05:18PM]
-
Pfizer Sales Likely Slowed As COVID-19 Vaccine Demand Wanes [Oct-31-22 04:31PM]
-
3 Things to Watch When Pfizer Announces Earnings Tuesday [Oct-31-22 04:30PM]
-
Drug/Biotech Stocks' Q3 Earnings on Nov 1: PFE, LLY & More [Oct-31-22 04:07PM]
-
Drugmakers Fight Over Lucrative Pneumonia Vaccines [Oct-31-22 02:58PM]
-
UPDATE 1-U.S. CDC director experiences COVID rebound after taking Pfizer's Paxlovid [Oct-31-22 01:03PM]
-
JOLTs Job Openings, Pfizer, BP Earnings: 3 Things to Watch [Oct-31-22 11:56AM]
-
New omicron subvariants accounted for more cases in New York region in latest week than BA.5, CDC data shows [Oct-31-22 11:53AM]
-
US Earnings to Watch: Pfizer, Qualcomm, CVS, Peloton, Coinbase, Uber [Oct-31-22 08:05AM]
-
My Prescription Is to Stand Aside on Pfizer Going Into Earnings [Oct-31-22 07:24AM]
-
Selling US$24m worth of Pfizer Inc. (NYSE:PFE) stock at high prices would have gotten insiders a handsome reward [Oct-31-22 07:00AM]
|
28-07-2022 |
PM |
6:45 AM ET (Jul 28) |
PFE |
Pfizer, Inc. |
287,450 |
2.04 |
1.83 |
1.07 |
Pfizer Non-GAAP EPS of $2.04 beats by $0.26, revenue of $27.7B beats by $1.5B, raisies lower end of FY22 EPS guidance [7/28/2022 6:46 AM] |
50.83 |
-0.72 (-1.41%) |
51.16 |
-0.39 (-0.76%) |
40.94 - 61.71 |
31,510,918 |
15,070,000 |
362,040 |
|
|
03-05-2022 |
PM |
6:45 AM ET (May 3) |
PFE |
Pfizer |
285,269 |
1.62 |
1.66 |
0.00 |
Pfizer Non-GAAP EPS of $1.62 beats by $0.05, revenue of $25.7B beats by $970M [5/3/2022 6:46 AM] |
49.38 |
1.03 (2.14%) |
47.78 |
-0.56 (-1.16%) |
37.96 - 61.71 |
27,044,856 |
27,080,000 |
765,260 |
|
-
Pfizer Non-GAAP EPS of $1.62 beats by $0.05, revenue of $25.7B beats by $970M [5/3/2022 6:46 AM]
-
Pfizer's COVID portfolio Comirnaty, Paxlovid star with ~$14.7B in Q1 sales [5/3/2022 7:45 AM]
-
Hot Stocks: PFE, CLX rise on earnings; EL drops; ASTS climbs on regulatory win [5/3/2022 12:25 PM]
-
Vaccine makers extend gains as Pfizer keeps 2022 COVID sales guidance intact [5/3/2022 1:45 PM]
-
Pfizer CEO Bourla says company prepared if modified COVID vaccine required [5/3/2022 2:20 PM]
-
US STOCKS-Wall Street up before Fed meet as tech buying punctuates volatile trade [May-02-22 05:00PM]
-
Why Moderna Shares Rallied Nearly 6% on Monday [May-02-22 04:24PM]
-
Drug/Biotech Stocks Q1 Earnings Due on May 3: PFE, BIIB & More [May-02-22 03:55PM]
-
MOBI Makes Their Post-Pandemic NYC Debut [May-02-22 03:19PM]
-
Moderna Bullish On COVID-19 Vaccine For Younger Kids To Be Ready Next Month: Reuters [May-02-22 01:22PM]
-
US STOCKS-Wall Street falls in volatile trading as focus turns to Fed meet [May-02-22 12:10PM]
-
Option Trade Profits If Pfizer Stock's Earning Reaction Isn't Crazy [May-02-22 12:03PM]
-
Pfizer Earnings, Airbnb Rebound, Starbucks Outlook: 3 Things to Watch [May-02-22 12:03PM]
-
Pfizers Paxlovid Stumbles as Covid Preventative. The Earnings Are Tuesday. [May-02-22 11:21AM]
-
COVID-19 cases on the rise across the U.S. as hospitalizations remain low [May-02-22 11:10AM]
-
US STOCKS-Wall Street inches higher as growth stocks rebound [May-02-22 10:52AM]
-
How Will Pfizer's (PFE) Key Drugs Perform in Q1 Earnings? [May-02-22 10:44AM]
-
South Africa hit by new subvariants of omicron that have been detected in the U.S. in small numbers [May-02-22 10:36AM]
-
Pfizer COVID-19 pill fails as preventive therapy in trial [May-02-22 09:48AM]
-
Pfizer Falls as Covid Pill Fails in Preventive Therapy Trial [May-02-22 09:39AM]
-
Pfizer Earnings: What to Look For From PFE [May-02-22 09:16AM]
-
Pfizer says Paxlovid doesn't work as a post-exposure prophylactic [May-02-22 08:08AM]
-
Pfizer Stock Slides As Data From Covid Antiviral Trial Disappoints Ahead Of Q1 Earnings [May-02-22 07:20AM]
-
Pfizer's COVID-19 Antiviral Pill Fails To Prevent Post Exposure Infection In Household Members [May-02-22 06:38AM]
-
Pfizer (PFE) COVID, Cancer Drugs Key to Top-Line Growth [May-02-22 06:33AM]
-
Poland has no 'rationale to invoke force majeure in Pfizer vaccine deal -EU official [May-02-22 06:22AM]
-
Pfizer Reports First-Quarter 2022 Results [May-03-22 06:45AM]
-
Pfizer keeps sales forecast for COVID antiviral pill unchanged [May-03-22 06:56AM]
-
UPDATE 2-Pfizer keeps sales forecasts for COVID pill, vaccine unchanged [May-03-22 06:57AM]
-
Pfizer keeps sales forecasts for COVID pill, vaccine unchanged [May-03-22 06:56AM]
-
Pfizer sticks to 2022 sales forecasts for COVID pill, vaccine [May-03-22 06:56AM]
-
UPDATE 3-Pfizer sticks to 2022 sales forecasts for COVID pill, vaccine [May-03-22 06:57AM]
-
2 High-Profile Blue Chip Stocks Making News Tuesday [May-03-22 08:23AM]
-
Pfizer Earnings: What Happened with PFE [May-03-22 07:54AM]
-
Pfizer Earnings and Revenue Soundly Beat Estimates, Though Paxlovid Sales Miss [May-03-22 09:06AM]
-
Pfizer Fails To Boost Its 2022 Outlook, And Shares Pay The Price [May-03-22 09:03AM]
-
Pfizer Stock Drops After Disappointing Sales Forecast for COVID Antiviral Drug [May-03-22 03:20AM]
-
Pfizer Fails To Boost Its 2022 Outlook, And Shares Waver [May-03-22 09:40AM]
-
Pfizer beats revenue estimates on COVID vaccine sales, misses on earnings [May-03-22 09:27AM]
-
Pfizer (PFE) Q1 Earnings and Revenues Miss Estimates [May-03-22 08:05AM]
-
UPDATE 4-Pfizer keeps COVID sales forecast unchanged as pandemic curbs ease [May-03-22 06:57AM]
-
Pfizer Fails To Boost Its 2022 Outlook, And Shares Dip [May-03-22 10:28AM]
-
Pfizer keeps COVID sales forecast unchanged as pandemic curbs ease [May-03-22 06:56AM]
-
3 Flaws in Pfizer's Otherwise Stellar Q1 Results [May-03-22 10:56AM]
-
Pfizer Posts Street Beating Q1 Earnings, Revises FY22 Profit Outlook [May-03-22 08:57AM]
-
Stock Market Gains As Fed Meeting Gets Underway; Job Openings Signal Tight Job Market [May-03-22 12:21PM]
-
BioNTech (BNTX) to Report Q1 Earnings: What's in the Cards? [May-03-22 11:22AM]
-
UPDATE 5-Pfizer keeps COVID sales forecast unchanged as pandemic curbs ease [May-03-22 06:57AM]
-
Stock Market Near Session Highs In Afternoon Trade; Job Openings Signal Tight Job Market [May-03-22 01:35PM]
-
Pfizer (PFE) Q1 Earnings & Sales Miss Estimates, Stock Down [May-03-22 10:42AM]
-
Fed's Crucial FOMC Meeting in Focus [May-03-22 10:37AM]
-
Amid a Big Week for the U.S. Economy, PFE, BP, EL Report [May-03-22 10:15AM]
-
Pfizer a victim of their own success amid lagging COVID vaccine sales: Analyst [May-03-22 10:04AM]
-
Dow Jones Falls Ahead Of Fed Meeting; 7 Key Earnings Movers [May-03-22 09:53AM]
-
Is Pfizer Stock A Buy As 2022 Covid Vaccine Sales Appear Front-Loaded? [May-03-22 01:48PM]
-
Volatility Grips Stocks as Fed Decision Looms: Markets Wrap [May-03-22 02:21PM]
-
Stocks Resume Advance as Bond Yields Push Lower: Markets Wrap [May-03-22 02:58PM]
-
Stocks Pare Gains in Volatile Session Before Fed: Markets Wrap [May-03-22 03:44PM]
-
Stock Market Today: Markets Climb Again Ahead of Likely Fed Hike [May-03-22 04:30PM]
-
Pfizer Fails To Boost Its 2022 Outlook, But Shares Rise [May-03-22 04:03PM]
-
Dizzying Pre-Fed Day Ends With Gains for Stocks: Markets Wrap [May-03-22 04:01PM]
-
Stock Market Today: Dow Closes Higher, But Bulls on Alert as Fed Decision Nears [May-03-22 12:47PM]
-
S&P 500 Climbs as Financials, Energy Rack Up Gains Ahead of Fed Decision [May-03-22 11:03AM]
|
08-02-2022 |
PM |
6:45 AM ET (Feb 8) |
PFE |
Pfizer, Inc. |
299,610 |
1.08 |
0.85 |
0.42 |
Pfizer Non-GAAP EPS of $1.08 beats by $0.21, revenue of $23.84B misses by $360M [2/8/2022 6:46 AM] |
51.67 |
-1.53 (-2.88%) |
50.45 |
-2.76 (-5.19%) |
33.36 - 61.71 |
58,855,352 |
32,770,000 |
3,929,403 |
|
-
All eyes on Pfizer Q4 earnings amid bolstered COVID-19 vaccine forecast [2/7/2022 11:44 AM]
-
ViiV Healthcare to report new data for long-acting HIV therapies [2/7/2022 7:26 AM]
-
South African regulator registers Chinese Sinopharm vaccine, Pfizer/BioNTech's COMIRNATY [2/7/2022 4:39 AM]
-
Pfizer Non-GAAP EPS of $1.08 beats by $0.21, revenue of $23.84B misses by $360M [2/8/2022 6:46 AM]
-
Pfizer drags rival COVID-19 vaccine makers after lower-than-expected 2022 guidance [2/8/2022 7:18 AM]
-
Dow Jones Futures Rise; 4 Top Stocks To Buy And Watch In Volatile Stock Market Rally [Feb-07-22 08:44PM]
-
Doliver Advisors, Lp Buys ProShares Short S&P500, Vanguard Growth ETF, SPDR Dividend ETF, ... [Feb-07-22 08:38PM]
-
UPDATE 1-U.S. funding to now cover study of Novavax's COVID-19 shot in adolescents [Feb-07-22 06:08PM]
-
REDW Wealth LLC Buys FlexShares High Yield Value Scored Bond Index ETF, Vanguard Short-Term ... [Feb-07-22 05:38PM]
-
New Study Suggests Omicron Booster Isn't Needed And Moderna Dips [Feb-07-22 04:04PM]
-
Some school districts lifting mask mandates as Omicron cases recede [Feb-07-22 02:45PM]
-
Pregnant women who contract COVID-19 are more likely to develop serious complications [Feb-07-22 02:20PM]
-
Best Growth Stocks to Buy for February 7th [Feb-07-22 01:41PM]
-
Silvant Capital Management LLC Buys Netflix Inc, Pfizer Inc, Natera Inc, Sells Visa Inc, ... [Feb-07-22 01:38PM]
-
Sanofi's (SNY) Enjaymo Gets FDA Nod For Rare Blood Disorder [Feb-07-22 01:02PM]
-
Pfizer's COVID cash pile opens opportunities for deals [Feb-07-22 01:01PM]
-
TBJ Plus: The 9 most admired companies in NC; Torry Holt delivers Super Bowl trophy; Fat bikes return to Wrightsville Beach [Feb-07-22 12:47PM]
-
The Zacks Analyst Blog Highlights: AbbVie, Merck, Eli Lilly, Novartis and Pfizer [Feb-07-22 12:31PM]
-
Spirit Airlines Soars on $6.6 Billion Frontier Deal [Feb-07-22 11:09AM]
-
How Will Pfizer's (PFE) Key Drugs Perform in Q4 Earnings? [Feb-07-22 10:54AM]
-
Pfizers Earnings Should Be Great. Why the Focus Could Shift. [Feb-07-22 10:10AM]
-
Drug/Biotech Stock Q4 Earnings Due Feb 8: PFE, INCY & DCPH [Feb-07-22 09:53AM]
-
Pfizer Earnings: What to Look For From PFE [Feb-07-22 09:12AM]
-
Pfizer as the Bull of the Day and Mesa Air Group have been highlighted as Zacks Bull and Bear of the Day [Feb-07-22 09:11AM]
-
Softbank leads $150M round for Boston biotech partnered with Big Pharma [Feb-07-22 06:15AM]
-
Bull of the Day: Pfizer Inc. (PFE) [Feb-07-22 06:00AM]
-
Is it Too Late to Buy Vaccine Stocks? [Feb-07-22 06:00AM]
-
2 Top Dividend Stocks to Bolster Your Retirement Portfolio in a Market Correction [Feb-07-22 06:00AM]
-
Australia Opens Borders; Vaccine Mandate Protests: Virus Update [Feb-07-22 05:27AM]
-
Monetta Financial Services Inc Buys Uber Technologies Inc, Netflix Inc, Merck Inc, Sells The ... [Feb-07-22 09:38PM]
-
Dow Jones Futures Fall; 4 Top Stocks To Buy And Watch In Volatile Stock Market Rally [Feb-08-22 06:55AM]
-
Pfizer stock falls after profit beats but revenue misses, even as COVID-19 vaccine sales of $12.5 billion top forecasts [Feb-08-22 07:02AM]
-
Pfizer forecasts $54 billion in 2022 sales of COVID vaccine, pill [Feb-08-22 06:56AM]
-
UPDATE 1-Pfizer forecasts $54 bln in 2022 sales of COVID vaccine, pill [Feb-08-22 06:53AM]
-
Pfizer vaccine, pill forecasts miss estimates; shares fall 4% [Feb-08-22 06:56AM]
-
UPDATE 2-Pfizer vaccine, pill forecasts miss estimates; shares fall 4% [Feb-08-22 06:53AM]
-
US STOCKS-Futures slip as earnings disappoint; Meta Platforms weak again [Feb-08-22 07:27AM]
-
Are Intranasal Sprays The Next $36 Billion Trend in Vaccine Stocks? [Feb-08-22 07:22AM]
-
Futures slip as earnings disappoint; Meta Platforms weak again [Feb-08-22 07:34AM]
-
Is Principal U.S. MegaCap ETF (USMC) a Strong ETF Right Now? [Feb-08-22 06:20AM]
-
Is Global X SuperDividend U.S. ETF (DIV) a Strong ETF Right Now? [Feb-08-22 06:20AM]
-
Dow Jones Futures Flat; Drug Giant Pfizer Slides On Earnings [Feb-08-22 08:18AM]
-
Pfizer COVID vaccine, pill forecasts miss estimates; shares fall 4% [Feb-08-22 06:56AM]
-
Dow Jones Futures Rise; Drug Giant Pfizer Slides On Earnings [Feb-08-22 08:31AM]
-
Pfizer Stock Drops After Earnings. Guidance Fell Short of Estimates. [Feb-08-22 08:26AM]
-
UPDATE 3-Pfizer COVID vaccine, pill forecasts miss estimates; shares fall 4% [Feb-08-22 06:53AM]
-
Pfizer Earnings: What Happened with PFE [Feb-08-22 08:30AM]
-
Wall St set for muted open on mixed earnings, Meta slides again [Feb-08-22 07:34AM]
-
Pfizer Could Soon Be A $100 Billion Company Why It Might Not Be Enough [Feb-08-22 08:59AM]
-
US STOCKS-Wall St set for muted open on mixed earnings, Meta slides again [Feb-08-22 08:51AM]
-
Dow Jones Rallies; Drug Giant Pfizer Slides On Earnings [Feb-08-22 09:36AM]
-
Sivik Global Healthcare LLC Buys SPDR Biotech ETF, Anthem Inc, Universal Health Services Inc, ... [Feb-08-22 09:38AM]
-
Hikari Tsushin, Inc. Buys Lockheed Martin Corp, Altria Group Inc, Phillips 66, Sells Wells ... [Feb-08-22 09:38AM]
-
Constitution Capital LLC Buys UnitedHealth Group Inc, Technology Select Sector SPDR ETF, ... [Feb-08-22 09:38AM]
-
S&P 500, Nasdaq down after mixed results; Meta weighs [Feb-08-22 07:34AM]
-
GLOBAL MARKETS-Wall Street starts groggy, euro stalled by Lagarde [Feb-08-22 09:48AM]
-
Pfizer reports revenue miss, weaker than expected COVID-19 vaccine sales forecast [Feb-08-22 09:43AM]
-
Stock Market Mixed As Small Caps Rise; This Blockbuster Deal Collapses [Feb-08-22 10:10AM]
-
High drug prices due to complex health care system in the U.S., Novo Nordisk CEO says [Feb-08-22 10:10AM]
-
Market check: Stocks mixed, crude oil slides, pharmaceuticals swing on earnings [Feb-08-22 10:29AM]
-
ICICI Prudential Asset Management Co Ltd Buys Unilever PLC, Cognizant Technology Solutions ... [Feb-08-22 10:38AM]
-
CCLA Investment Management Ltd Buys PepsiCo Inc, PayPal Holdings Inc, Brookfield Renewable ... [Feb-08-22 10:38AM]
-
Peloton Jumps on CEO Departure, Job Cuts, Barry McCarthy to Take Top Spot [Feb-08-22 10:19AM]
-
At least 5 states plan to ease face mask mandates against advice of CDC, as U.S. daily death toll hovers close to 2,600 [Feb-08-22 10:43AM]
-
Why Pfizer's Falling but Harley's Riding Higher Tuesday [Feb-08-22 10:53AM]
-
US STOCKS-S&P 500, Nasdaq slip as Pfizer, megacap stocks drag [Feb-08-22 10:48AM]
-
At least 5 states plan to ease face-mask mandates against advice of CDC, as U.S. daily death toll hovers close to 2,600 [Feb-08-22 10:43AM]
-
COVID-19: States look to relax mask mandates, infected deer pose health risk [Feb-08-22 11:22AM]
-
GLOBAL MARKETS-Wall Street turns higher after groggy open, euro stalled by Lagarde [Feb-08-22 11:30AM]
-
NVIDIA/ARM Deal Off, Peloton CEO Steps Down [Feb-08-22 10:34AM]
-
UPDATE 1-EU regulator reviews extending Pfizer COVID booster for kids aged 12-15 [Feb-08-22 12:05PM]
-
Stock Market Improves At Midday As These Stocks Top Buy Points [Feb-08-22 11:56AM]
-
Markets Await More Earnings Data [Feb-08-22 11:04AM]
-
Pfizer (PFE) Q4 Earnings Top, 2022 Sales View Grim, Stock Down [Feb-08-22 10:56AM]
-
Perennial Advisors, LLC Buys Fastenal Co, Adobe Inc, Automatic Data Processing Inc, Sells ... [Feb-08-22 01:38PM]
-
Handelsbanken Fonder AB Buys FREYR Battery, Pfizer Inc, GXO Logistics Inc, Sells SVB Financial ... [Feb-08-22 01:38PM]
-
Best Growth Stocks to Buy for February 8th [Feb-08-22 11:52AM]
-
Is Pfizer Stock A Buy Or A Sell After $100 Billion In Sales Guidance Lags Expectations? [Feb-08-22 02:00PM]
-
Stocks Rally as Amgen, Peloton, Travel Companies Push Markets Higher [Feb-08-22 01:54PM]
-
NovaPoint Capital, LLC Buys iShares iBonds Dec 2023 Term Corporate ETF, Financial Select Sector ... [Feb-08-22 02:38PM]
-
Pfizer eyes $100B year on pandemic boon for 2022 [Feb-08-22 03:27PM]
-
Pfizer expects a record $100 billion in revenue this year, thanks to COVID vaccines and treatments [Feb-08-22 04:44PM]
-
Vaccine Stocks Drop After Pfizers Covid Sales-Forecast Miss [Feb-08-22 04:25PM]
-
Pfizer Stock Fell 2.8%. Did Investors Misunderstand the Revenue Guidance? [Feb-08-22 04:16PM]
-
Doctor on developing global COVID-19 vaccine: We got zero help from the U.S. government [Feb-08-22 04:14PM]
-
Why Shares of Pfizer Fell 10.8% in January [Feb-08-22 03:52PM]
-
Pfizer Forecasts $54 Billion in 2022 Sales From Its Covid-19 Vaccine, Treatment [Feb-08-22 02:44PM]
|
02-11-2021 |
PM |
6:45 AM ET (Nov 2) |
PFE |
Pfizer, Inc. |
242,100 |
1.34 |
1.08 |
0.72 |
Pfizer EPS beats by $0.25, beats on revenue, raises guidance [11/2/2021 6:46 AM] |
45.48 |
1.84 (4.22%) |
45.49 |
0.01 (0.02%) |
33.36 - 51.86 |
59,853,956 |
23,520,000 |
1,389 |
|
-
Hot Stocks: UAA, PFE, CAR rise on earnings; GNRC falls; ROG spikes on DD merger deal [11/2/2021 8:41 AM]
-
Pfizer more than doubles Q3 revenue thanks to COVID-19 vaccine sales [11/2/2021 7:28 AM]
-
Pfizer CEO: Supplies ready when government approves COVID vaccine for kids [11/2/2021 2:35 PM]
-
CDC advisory panel unanimously recommends authorization of Pfizer vaccine for children [11/2/2021 5:05 PM]
-
CDC gives green light for Pfizer COVID vaccine for children [11/2/2021 8:08 PM]
-
UPDATE 3-White House says 15 mln COVID-19 shots will roll out to children by next week [Nov-01-21 05:29PM]
-
3 Smart Stocks to Hedge Against Inflation [Nov-01-21 04:35PM]
-
U.S. administers about 423 million doses of COVID-19 vaccines - CDC [Nov-01-21 04:25PM]
-
Moderna Dives As FDA Delays Covid Vaccine In Teens To Investigate 'Rare' Side Effect [Nov-01-21 04:07PM]
-
Coronavirus: 'We have to be cautious' going into the winter season, doctor says [Nov-01-21 04:05PM]
-
11 Best Covid Vaccine and Pill Stocks To Invest In [Nov-01-21 03:21PM]
-
COVID SCIENCE-Heart attack patients with COVID-19 have lower survival rate; Israeli data supports use of Pfizer booster [Nov-01-21 02:29PM]
-
Is Pfizer Stock A Buy As The CDC Considers Its Covid Shot In Children? [Nov-01-21 01:52PM]
-
What to expect this week as the U.S. prepares to offer BioNTech and Pfizers COVID-19 shots to young children [Nov-01-21 01:42PM]
-
CORRECTED-UPDATE 2-U.S. vaccines for children plan fully operational next week, White House says [Nov-01-21 12:59PM]
-
Pharmaceutical Giant Pfizer to Deliver Healthy Q3 Earnings [Nov-01-21 12:12PM]
-
How Will Pfizer's (PFE) Key Drugs Impact Its Q3 Earnings? [Nov-01-21 11:00AM]
-
Pfizer Earnings: What to Look For From PFE [Nov-01-21 10:07AM]
-
Pfizer Stock: 3 Levels You Must Know When It Reports Earnings [Nov-01-21 08:53AM]
-
The CDC Meets Tuesday on Kids Covid Vaccines. What to Know. [Nov-01-21 08:27AM]
-
Analysts Expect Pfizer (PFE) to Deliver a Blowout Q3 [Nov-01-21 06:33AM]
-
The CDC Meets Tuesday on Kids Covid Vaccines. What to Know. [Nov-01-21 05:30AM]
-
UAE approves Pfizer COVID-19 vaccine for ages 5-11 [Nov-01-21 12:51AM]
-
REFILE-Bahrain approves Pfizer COVID vaccine for children aged 5-11 [Nov-02-21 01:23AM]
-
Here's How Much Extra Money Pfizer Will Make From Vaccines for Younger Kids This Year [Nov-02-21 05:55AM]
-
PFIZER REPORTS THIRD-QUARTER 2021 RESULTS [Nov-02-21 06:45AM]
-
UPDATE 1-Pfizer raises COVID-19 vaccine sales forecast to $36 bln for 2021 [Nov-02-21 06:50AM]
-
Pfizer raises COVID-19 vaccine sales forecast to $36 billion for 2021 [Nov-02-21 06:48AM]
-
Pfizer Stock In Limbo At 50-Day Line As CDC Preps To Discuss Covid Shot In Children [Nov-02-21 07:00AM]
-
Pfizer shares jump 2.5% premarket as earnings beat, company raises guidance [Nov-02-21 07:00AM]
-
U.S. CDC advisers to vote on COVID-19 vaccine in young children [Nov-02-21 07:00AM]
-
Pfizer Stock Jumps After Q3 Earnings Beat; Sees $36 Billion In COVID Vaccine Sales [Nov-02-21 02:54AM]
-
US STOCKS-Futures slip on Fed angst; Tesla slides after record run [Nov-02-21 07:03AM]
-
Pfizer Stock Charges Higher as Drug Maker Boosts 2021 Guidance [Nov-02-21 07:03AM]
-
UPDATE 2-Pfizer raises COVID-19 vaccine sales forecast to $36 bln for 2021 [Nov-02-21 06:50AM]
-
What to expect from Tuesdays CDC meeting about BioNTech and Pfizers COVID-19 shots for young children [Nov-02-21 07:53AM]
-
A Pfizer Drug Moves Closer to Approval in Another Important Indication [Nov-02-21 08:10AM]
-
Pfizer Stock Jumps On Expectations For $36 Billion In 2021 Covid Vaccine Sales [Nov-02-21 08:58AM]
-
US STOCKS-Wall St eyes mixed open on Fed angst; Tesla slides after record run [Nov-02-21 08:57AM]
-
Pfizer Earnings: What Happened with PFE [Nov-02-21 08:44AM]
-
Pfizer (PFE) Beats Q3 Earnings and Revenue Estimates [Nov-02-21 08:05AM]
-
Earnings: Under Armour, Ralph Lauren, Clorox, and Pfizer all beat estimates [Nov-02-21 09:48AM]
-
Shipping of kid-sized doses of Pfizer-BioNTech vaccine under way ahead of CDC recommendation [Nov-02-21 09:46AM]
-
Pfizer Raises 2021 Forecast, But Sees Shot Sales Falling Next Year [Nov-02-21 09:52AM]
-
US STOCKS-S&P 500, Nasdaq hit record highs on earnings boost; Fed angst prevails [Nov-02-21 10:28AM]
-
Was The Smart Money Right About Pfizer Inc. (PFE)? [Nov-02-21 10:34AM]
-
Fed Set to Start Vital FOMC Meeting [Nov-02-21 10:49AM]
-
Pfizer (PFE) Q3 Earnings Top, COVID Vaccine Drives 2021 View Up [Nov-02-21 10:48AM]
-
Fed Meets, Tapering in Our Midst; Pfizer Beats in Q3 [Nov-02-21 10:21AM]
-
US STOCKS-Wall St scales record peaks on earnings cheer; Fed meeting in focus [Nov-02-21 12:24PM]
-
Mid-Morning Market Update: Markets Edge Higher; Pfizer Boosts FY21 Outlook [Nov-02-21 10:12AM]
-
Why BioNTech Shares Are Trading Higher Today [Nov-02-21 10:30AM]
-
UPDATE 1-U.S. CDC advisers to vote on COVID-19 vaccine for young children [Nov-02-21 01:35PM]
-
Why These 10 Stocks Are Trending on Tuesday [Nov-02-21 01:57PM]
-
US STOCKS-Wall Street rises to records, underpinned by strong earnings reports [Nov-02-21 02:12PM]
-
Is Pfizer Stock A Buy On Projections For $36 Billion In Full-Year Covid Vaccine Sales? [Nov-02-21 02:19PM]
-
U.S. administers 423.9 mln doses of COVID-19 vaccines - CDC [Nov-02-21 03:02PM]
-
Mid-Day Market Update: Avis Budget Surges After Q3 Results; Chegg Shares Plunge [Nov-02-21 12:08PM]
-
Is Johnson & Johnson a Good COVID Stock to Buy? [Nov-02-21 03:30PM]
-
CDC gives final approval for Pfizers COVID shot for kids 5-11 [Nov-02-21 07:51PM]
-
Democrats Reach Deal on Drug Prices, Schumer Says. Pharma Stocks Are Steady. [Nov-02-21 06:22PM]
-
Pfizer Stock Jumps After CDC Advisors Recommend Covid Shots For Children [Nov-02-21 06:02PM]
-
Why Pfizer Stock Popped Today [Nov-02-21 05:52PM]
-
As Covid-19 Vaccines Approach for Young Kids, Many Parents Plan to Wait [Nov-02-21 05:31PM]
-
CDC Advisers Unanimously Back Pfizer Vaccine for Children 5 to 11 [Nov-02-21 05:26PM]
-
Pfizer Raises Covid-19 Vaccine Forecast as Sales More Than Double [Nov-02-21 05:08PM]
-
Stock Market Today: Dow 36,000 at Last! [Nov-02-21 04:38PM]
-
US STOCKS-Wall Street mints record highs, helped by strong earnings; Fed up next [Nov-02-21 04:21PM]
-
Pfizer CEO Says Poor Countries Need to Order Covid Vaccines Earlier [Nov-02-21 04:16PM]
-
Dr. Mendelson: Pfizer Approval For Kids Very Exciting [Nov-02-21 04:13PM]
-
Pfizer CEO Projects $29 Billion in Sales of Covid Vaccine [Nov-02-21 04:07PM]
-
Coronavirus: We must weigh the risk of vaccination for kids vs. risk of not getting the vaccine, doctor says [Nov-02-21 04:01PM]
-
US STOCKS-Wall Street mints record highs, helped by strong earnings; Fed up next [Nov-02-21 04:00PM]
-
CDC Recommends Pfizer Covid Vaccine for Kids 5 to 11 [Nov-02-21 08:11PM]
|
28-07-2021 |
PM |
6:45 AM ET (Jul 28) |
PFE |
Pfizer, Inc. |
234,040 |
1.07 |
0.96 |
0.78 |
Pfizer EPS beats by $0.09, beats on revenue [7/28/2021 6:47 AM] |
43.43 |
1.33 (3.16%) |
42.40 |
0.30 (0.71%) |
32.80 - 43.74 |
49,551,485 |
26,330,000 |
904,887 |
|
-
Pfizer raises 2021 guidance above expectations on strong COVID-19 vaccine sales [7/28/2021 7:23 AM]
-
England allows fully vaccinated travelers from U.S. and EU to avoid COVID-19 quarantine [7/28/2021 12:41 PM]
-
Pfizer/BioNTech COVID-19 shot’s efficacy drops to 84% from 96% in six months - study [7/28/2021 1:21 PM]
-
White House tells federal agencies to mandate masks indoors in high COVID areas - Reuters [7/28/2021 2:10 PM]
-
Pfizer CEO 'very, very confident' COVID booster will protect against Delta variant [7/28/2021 2:17 PM]
-
CDC urges some vaccinated to wear masks again [Jul-27-21 05:37PM]
-
CDC: Vaccinated Americans should start wearing masks again indoors in areas with high COVID-19 transmission rates [Jul-27-21 04:31PM]
-
Theres a great opportunity that well have another variant: Doctor [Jul-27-21 02:12PM]
-
Why Earnings Season Could Be Great for Pfizer (PFE) [Jul-27-21 12:08PM]
-
Pfizer Earnings: What to Look For From PFE [Jul-27-21 11:55AM]
-
Drug/Biotech Stock Earnings on Jul 28: PFE, GSK, BMY, BMRN & TLRY [Jul-27-21 11:14AM]
-
Argentina signs deal with Pfizer for 20 mln COVID-19 vaccine doses, minister says [Jul-27-21 09:52AM]
-
200 Million More Reasons to Buy Pfizer Stock [Jul-27-21 05:52AM]
-
EU says it is on track for 70% vaccination target by end summer [Jul-27-21 04:19AM]
-
UPDATE 2-Antibodies from Sinovac's COVID-19 shot fade after about 6 months, booster helps - study [Jul-27-21 02:52AM]
-
Legal wrangles hold up U.S. vaccine donations to India [Jul-28-21 02:05AM]
-
UPDATE 1-Guatemala renegotiates Sputnik V contract to receive 8 mln doses, says president [Jul-27-21 10:27PM]
-
U.S. to ship 4 mln COVID-19 vaccine doses to Nigeria, 5.66 mln to South Africa [Jul-28-21 03:00AM]
-
3 Big Hints That COVID Vaccine Booster Doses Are on the Way [Jul-28-21 05:52AM]
-
UPDATE 1-Pfizer raises estimates for 2021 sales of COVID-19 vaccine to $33.5 bln [Jul-28-21 06:53AM]
-
Pfizer raises estimates for 2021 sales of COVID-19 vaccine to $33.5 billion [Jul-28-21 06:48AM]
-
PFIZER REPORTS SECOND-QUARTER 2021 RESULTS [Jul-28-21 06:45AM]
-
Pfizer Blasts Earnings Forecast, Sees $33.5 Billion in COVID Vaccine Sales [Jul-28-21 02:52AM]
-
Pfizer Earnings Beat Views, Guidance Raised On Coronavirus Vaccine [Jul-28-21 07:06AM]
-
Pfizer raises 2021 COVID-19 vaccine sales forecast to $33.5 billion [Jul-28-21 06:48AM]
-
UPDATE 2-Pfizer raises 2021 COVID-19 vaccine sales forecast to $33.5 billion [Jul-28-21 06:53AM]
-
Pfizer's COVID-19 vaccine generated $7.8 billion in revenue in the second quarter [Jul-28-21 07:35AM]
-
Pfizer shares limited data about its COVID-19 booster candidate, says it ups protection against the delta variant [Jul-28-21 08:01AM]
-
Pfizer Earnings: What Happened with PFE [Jul-28-21 07:52AM]
-
3 Top Robinhood Stocks That Shrewd Investors Should Buy Right Now [Jul-28-21 08:11AM]
-
Pfizer Says It Will Now Sell $33.5 Billion of Its Covid-19 Vaccine This Year [Jul-28-21 08:38AM]
-
UPDATE 3-Pfizer raises 2021 COVID-19 vaccine sales forecast to $33.5 billion [Jul-28-21 06:53AM]
-
Here's What the Surge in COVID's Delta Variant Could Mean for Pfizer's Stock [Jul-28-21 08:39AM]
-
Pfizer (PFE) Q2 Earnings and Revenues Surpass Estimates [Jul-28-21 08:05AM]
-
Pfizer Stock Lingers In Breakout Territory After Hiking Its Covid Vaccine Outlook [Jul-28-21 09:44AM]
-
Pfizer Covid Vaccine Sales Are Booming and Should Keep on Booming [Jul-28-21 09:37AM]
-
Spotify misses user target, Boeing reports surprise Q2 profit, Pfizer raises guidance [Jul-28-21 10:09AM]
-
Pfizer Q2 Results Beat Wall Street Expectations; Expects $33B From COVID-19 Vax Sales In 2021 [Jul-28-21 07:06AM]
-
Zacks Earnings ESP: A Better Way to Find Earnings Surprises for Medical [Jul-28-21 08:50AM]
-
Pfizer (PFE) Q2 Earnings Beat, View Up on COVID-19 Vaccine [Jul-28-21 09:56AM]
-
Pfizer Expects $33.5 Billion In Full-Year Covid Vaccine Sales Is PFE Stock A Buy? [Jul-28-21 12:03PM]
-
Earnings Data Deluge [Jul-28-21 10:59AM]
-
Trade Numbers Sink Near Record, Q2 Earnings Beats for PFE, BA & MCD [Jul-28-21 10:30AM]
-
AbbVie Stock Is Rising Despite A Pfizer Setback Is It A Buy Or A Sell? [Jul-28-21 12:48PM]
-
Ripple effects of the CDC indoor mask guidance [Jul-28-21 01:47PM]
-
Covid-19 vaccine booster shots will become a reality: Doctor [Jul-28-21 01:51PM]
-
Pfizer beats on earnings, raises 2021 guidance on vaccine sales [Jul-28-21 02:14PM]
-
[video]Pfizer Price Targets? I've Got Them for You [Jul-28-21 10:14AM]
-
Pfizer: 'No issues' in testing for COVID-19 kid vaccine as Delta variant rises [Jul-28-21 03:26PM]
-
Why BioNTech Stock Shot Higher on Wednesday [Jul-28-21 06:41PM]
-
Why Pfizer Shot Higher Today [Jul-28-21 04:13PM]
-
Why Moderna Stock Jumped Today [Jul-28-21 03:46PM]
-
Pfizer authorizes $1 billion for oral COVID-19 treatment, CEO says [Jul-28-21 03:45PM]
-
Integra's Update On FY21 Acell Revenues To Weigh On Stock, Piper Sandler Says [Jul-28-21 02:29PM]
-
Third Dose Of Pfizer-BioNTech's COVID-19 Vaccine Boosts Protection Against Delta Variant, New Data Reveals [Jul-28-21 02:21PM]
-
WHO Is Currently Not In Favor Of COVID Booster Shots Citing Lack Of Data: CNBC [Jul-28-21 12:55PM]
|
04-05-2021 |
PM |
6:45 AM ET (May 4) |
PFE |
Pfizer, Inc. |
215,320 |
0.93 |
0.79 |
0.80 |
Pfizer EPS beats by $0.15, beats on revenue [5/4/2021 6:46 AM] |
39.95 |
0.12 (0.30%) |
39.97 |
0.14 (0.35%) |
29.96 - 43.08 |
45,616,109 |
27,300,000 |
2,772,212 |
|
-
ViiV Healthcare initiates rolling submission of cabotegravir in U.S. for HIV prevention [5/4/2021 8:56 AM]
-
Pfizer plans to file for full approval for COVID-19 vaccine by the end this month [5/4/2021 9:15 AM]
-
Enrollment in Pfizer elranatamab trial paused amid cases of peripheral neuropathy [5/4/2021 10:47 AM]
-
Shares of major drug makers in focus as House committees hold hearings on drug pricing bill [5/4/2021 11:40 AM]
-
Biden says vaccination effort will focus on adolescents, hesitant adults (updated) [5/4/2021 3:09 PM]
-
NYSE Eases Trader Curbs; Australia Backlash Grows: Virus Update [May-03-21 08:45PM]
-
Pfizer COVID-19 vaccine expected to get FDA approval for kids 12-15 this week [May-03-21 08:00PM]
-
AbbVie's Humira Still Number 1 in Drug Sales [May-03-21 06:40PM]
-
UPDATE 2-U.S. FDA set to authorize Pfizer COVID-19 shot for ages 12-15 early next week - NYT [May-03-21 05:36PM]
-
Vaccine Hesitancy Ticks Down Here's What That Means For Covid Stocks [May-03-21 04:54PM]
-
Brazil looks to new Pfizer contract to speed up vaccinations [May-03-21 04:42PM]
-
Was The Smart Money Right About Pfizer Inc. (PFE)? [May-03-21 04:17PM]
-
BioNTech Hits Record as Vaccine Success Spurs on Biotechs [May-03-21 04:14PM]
-
A one size fits all policy for reopening travel is very concerning: Doctor [May-03-21 02:32PM]
-
Pfizer says it told India there no safety concern with its COVID-19 vaccine [May-03-21 02:06PM]
-
Pfizers Earnings Are Tuesday. Heres What to Expect. [May-03-21 01:19PM]
-
Why BioNTech Stock Is Jumping Today [May-03-21 01:03PM]
-
Pfizer's COVID-19 Pill Could Be Here By Year-End: Investor Impact [May-03-21 12:51PM]
-
With earnings on track for best growth in more than a decade, here come Uber, Lyft and the vaccine makers [May-03-21 12:48PM]
-
Dow Jones Rallies 300 Points To Lead Stock Market; Is A New Closing High Next? [May-03-21 12:22PM]
-
Pfizer Earnings: What to Look For From PFE [May-03-21 12:11PM]
-
People should focus on wearing masks indoors 'where it matters the most': Doctor [May-03-21 11:39AM]
-
COVID-19 latest: U.S. cases fall, EU looks to reopen, India cases on the rise [May-03-21 11:14AM]
-
Pfizer's (PFE) Key Drugs Likely to Drive Its Q1 Earnings [May-03-21 11:14AM]
-
Pfizer says it submitted application for COVID-19 vaccine to Indian regulators 'months ago' [May-03-21 11:13AM]
-
UPDATE 1-India's vaccinations plummet as coronavirus infections soar [May-03-21 11:02AM]
-
Uber, Pfizer, ViacomCBS, General Motors, and Other Stocks to Watch This Week [May-03-21 09:35AM]
-
Is a Beat in Store for BioNTech (BNTX) This Earnings Season? [May-03-21 09:34AM]
-
3 Big Drugmaker Stocks to Watch Out For Amid Pandemic Woes [May-03-21 09:00AM]
-
BioNTech Jumps on EU Drug Regulator's Review of Covid Vaccine for Kids [May-03-21 07:34AM]
-
Is It Time To Buy AbbVie Stock As It Barrels Toward A New Buy Point? [May-03-21 07:15AM]
-
The Zacks Analyst Blog Highlights: Eli Lilly, Merck, GlaxoSmithKline, Novartis and Johnson & Johnson [May-03-21 06:42AM]
-
The 2 Numbers I'll Be Looking for in Moderna's Earnings Report This Week [May-03-21 06:00AM]
-
India's vaccinations plummet as coronavirus infections soar [May-03-21 02:44AM]
-
Pfizer in talks with India over expedited approval for COVID-19 vaccine [May-03-21 02:32AM]
-
Astellas' XTANDI (enzalutamide) Approved by European Commission for Men with Metastatic Hormone-Sensitive Prostate Cancer [May-04-21 02:00AM]
-
U.K. On Course to Ease Lockdown; Denmark Drops J&J: Virus Update [May-04-21 01:32AM]
-
BioNTech/Pfizer Covid vaccine to be approved for 12- to 15-year-olds [May-03-21 08:00PM]
-
BioNTech/Pfizer Covid vaccine to be approved for 12 to 15-year-olds [May-03-21 08:00PM]
-
UPDATE 1-South Africa allocates an extra $276 mln to fight COVID-19 [May-04-21 03:28AM]
-
India Suspends Cricket; U.K. Sees End to Lockdown: Virus Update [May-04-21 05:03AM]
-
Gates Divorce, Ethereum and Pfizer: 5 Things You Must Know Tuesday [May-04-21 01:08AM]
-
US set to approve Pfizer Covid vaccine for 12- to 15-year-olds [May-03-21 08:00PM]
-
Travel stocks rally as EU prepares to open borders to vaccinated holidaymakers [May-04-21 06:07AM]
-
Coronavirus tally: Global cases of COVID-19 top 153.5 million and India's death toll above 200,000 [May-04-21 06:22AM]
-
Pfizer lifts annual sales forecast for COVID-19 vaccine [May-04-21 06:54AM]
-
PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS [May-04-21 06:45AM]
-
Pfizer Beats Earnings Forecast, Sees $26 Billion In COVID Vaccine Sales [May-04-21 02:55AM]
-
Reopening Trades, CO2 Record, Pfizer, Aramco Earnings - What's Moving Markets [May-04-21 02:26AM]
-
Pfizer beats earnings expectations and lifts guidance, as COVID-19 revenue outlook increases 73% [May-04-21 07:01AM]
-
Pfizer lifts sales forecast for COVID-19 vaccine to $26 billion [May-04-21 06:54AM]
-
Pfizer Boosts Forecast for Covid-19 Shot Sales as Profits Jump [May-04-21 07:03AM]
-
Europe Reviews China Shot; U.K. Sees Lockdown End: Virus Update [May-04-21 07:33AM]
-
Pfizer Earnings Top, Guidance Raised On Coronavirus Vaccine; Stock Rises In Buy Zone [May-04-21 07:49AM]
-
Dow set for muted action Tuesday as investors await Yellen remarks, parse earnings from CVS, Pfizer [May-04-21 07:46AM]
-
Pfizer Inc. to Host Earnings Call [May-04-21 07:45AM]
-
Pfizer Boosts Forecast for Covid Shot Sales as Profits Jump [May-04-21 08:10AM]
-
The Stock Market Is Slipping. Why Strong Earnings Arent Enough. [May-04-21 08:25AM]
-
Pfizer (PFE) Q1 Earnings and Revenues Surpass Estimates [May-04-21 08:05AM]
-
Pfizer Earnings: What Happened with PFE [May-04-21 08:31AM]
-
U.S. stock-index futures tilt lower, with tech shares under pressure [May-04-21 09:12AM]
-
Pfizer Is Gaining, CVS Is Jumping, and the Stock Market Is Slipping [May-04-21 09:03AM]
-
Pfizer Posts Strong Earnings and Boosts Its Covid-19 Vaccine Sales Forecast. What You Need to Know. [May-04-21 09:20AM]
-
Pfizers Vaccine Windfall; Singapore Cracks Down: Virus Update [May-04-21 09:14AM]
-
Zacks Industry Outlook Highlights: Johnson & Johnson, AstraZeneca and Pfizer [May-04-21 08:14AM]
-
Pfizer posts earnings beat driven by COVID-19 revenue [May-04-21 09:22AM]
-
U.S. stocks dip in early trade, with tech shares under pressure [May-04-21 09:46AM]
-
Pfizer Stock Eyes Breakout On Call For $26 Billion In Covid Vaccine Sales [May-04-21 09:56AM]
-
Dow down 280 points, with tech shares under heavy pressure [May-04-21 10:32AM]
-
Pfizer Sees $26 Billion From Vaccine, With Big Potential Ahead [May-04-21 10:25AM]
-
Pfizers Vaccine Drove a Big Earnings Beat. What It Means for the Stock. [May-04-21 10:24AM]
-
Pfizer Knocks It Out of the Park With Its Q1 Results [May-04-21 10:56AM]
-
Indias COVID-19 case tally tops 20 million after nearly doubling in three months [May-04-21 10:37AM]
-
Pfizer, UnderArmour Beat; Trade Deficit at All-Time Low [May-04-21 10:29AM]
-
Chicago Auto Show Returning; Singapore Cracks Down: Virus Update [May-04-21 11:27AM]
-
Pfizer Reports Better-Than-Expected 1Q Results, Lifts COVID-19 Vaccine Sales Outlook [May-04-21 11:14AM]
-
Pfizers Covid-19 Vaccine Could Be Approved for 12- to 15-Year-Olds By Next Week [May-04-21 11:39AM]
-
Why BioNTech Stock Is Sinking Today [May-04-21 11:50AM]
-
Pfizer (PFE) Q1 Earnings Beat, COVID-19 Vaccine Boosts Sales [May-04-21 11:55AM]
-
U.S. to Reallocate Doses; Chicago Auto Show Back: Virus Update [May-04-21 01:28PM]
-
CVS banks on future gains from pediatric vaccines as hesitant adults drive recent COVID vaccination decline [May-04-21 01:27PM]
-
Pfizer Sees $26 Billion From Covid Shot, Big Potential Ahead [May-04-21 01:48PM]
-
Returning to normal doesnt have to be the the goal amid COVID-19 recovery: Doctor [May-04-21 02:02PM]
-
Dow slides, Nasdaq tumbles 2.6% as fears of Fed tapering put investors on edge [May-04-21 02:12PM]
-
Is Pfizer Stock A Buy As It Flirts With A Breakout On Vaccine-Fueled Earnings? [May-04-21 02:33PM]
-
Pfizer CEO: 'We do think our stock is undervalued' [May-04-21 02:54PM]
-
'Were entering the harder phase' of coronavirus vaccination [May-04-21 02:49PM]
-
Pfizers next play: A vaccine maker and pandemic partner to governments [May-04-21 03:00PM]
-
How businesses are tracking their employee's vaccination status and well-being amid COVID-19 recovery [May-04-21 03:18PM]
-
Biden aims to have 70% of U.S. adults receive first vaccine shot by July 4th [May-04-21 02:44PM]
-
Pfizer in talks with India for COVID-19 vaccine [May-04-21 03:35PM]
-
Pfizer: Anticipated Growth at a Fair Value [May-04-21 06:47PM]
-
UPDATE 1-People aged over 50 in Britain to be offered 3rd COVID vaccine shot in autumn -The Times [May-04-21 06:35PM]
-
Pfizer (PFE) Gains As Market Dips: What You Should Know [May-04-21 05:45PM]
-
India Deaths May Double; Seychelles Cases Surge: Virus Update [May-04-21 05:44PM]
-
What happened in the stock market today? Tech sees worst day since March, Dow ekes out gain [May-04-21 05:03PM]
-
Pfizer Covid Vaccine Set to Become Highest-Selling Medication Ever [May-04-21 04:25PM]
-
Returning to normal doesnt have to be the goal amid COVID-19 recovery: Doctor [May-04-21 02:02PM]
-
Pfizer's BCMA/CD3 Bispecific Candidate Study Derailed Amid Safety Woes [May-04-21 12:52PM]
-
The Top 10 Dividend Stocks to Buy in 2021 [May-04-21 08:50PM]
-
Vaccine Sales Lift Pfizers Quarterly Results [May-04-21 06:29PM]
|
02-02-2021 |
PM |
6:45 AM ET (Feb 2) |
PFE |
Pfizer, Inc. |
199,550 |
0.42 |
0.45 |
0.55 |
Pfizer EPS misses by $0.04, beats on revenue [2/2/2021 6:46 AM] |
35.01 |
-0.79 (-2.21%) |
36.00 |
0.20 (0.56%) |
26.43 - 43.08 |
77,300,331 |
37,910,932 |
1,694,544 |
|
|
27-10-2020 |
PM |
6:45 AM ET (Oct 27) |
PFE |
Pfizer, Inc. |
212,160 |
0.72 |
0.70 |
0.75 |
Pfizer EPS beats by $0.01, misses on revenue [10/27/2020 6:47 AM] |
37.48 |
-0.87 (-1.15%) |
37.30 |
-0.62 (-1.64%) |
27.88 - 40.97 |
25,985,316 |
24,634,184 |
431,828 |
|
|
28-07-2020 |
PM |
6:45 AM ET (Jul 28) |
PFE |
Pfizer, Inc. |
208,860 |
0.78 |
0.64 |
0.80 |
Pfizer EPS beats by $0.12, beats on revenue [7/28/2020 6:49 AM] |
39.12 |
1.58 (4.20%) |
0.0 |
0.0 (0.00%) |
27.88 - 43.00 |
29,295,802 |
35,413,240 |
0 |
|
|